Panacea Life Sciences Holdings, Inc. (PLSH) Total liabilities 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) total liabilities at each fiscal year-end, per SEC filings.
$26.3MFY2023 · since FY2014: $39,043 → $26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $26.3M | +21.5% |
| FY2022 | $21.6M | +29.7% |
| FY2021 | $16.7M | -32.3% |
| FY2020 | $24.7M | +497.0% |
| FY2019 | $4.1M | +20.1% |
| FY2018 | $3.4M | +44.0% |
| FY2017 | $2.4M | +282.1% |
| FY2016 | $624,974 | +250.7% |
| FY2015 | $178,205 | +356.4% |
| FY2014 | $39,043 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice